February 21, 2017
Fairmont Royal York Hotel, Toronto
Benefits Canada is proud to present the 2017 Employers Cancer Care Summit
The theme of this year’s conference is:
The Pipeline, The Plan, The Patient
The oncology pipeline is expanding. There are currently hundreds of cancer drugs in development. How will new treatments impact patients, caregivers and payers? What are the education gaps that plan sponsors need to understand now? What are the opportunities for the redesign of benefits plans to support cancer patients?
The Employers Cancer Care Summit will answer these questions while also informing plan sponsors about various aspects of the cancer journey and its relevance to the workplace.
The 2017 Employers Cancer Care Summit could feature presentations on:
- What does the cancer landscape look like? Trends and treatments.
- Immunoncology: What is it? What does it mean for patient outcomes?
- Robustness of oral therapies: What is precision therapy? What do oral medications mean for plan sponsors? How are patients treated when their drugs are taken out of a cancer centre? How are payers perceiving orals?
- How are patients taking ownership of their treatment and how is it changing?
- How will new oral therapy treatments, now out of cancer centres, include case management and the role of the pharmacist to ensure better outcomes?
- Caregivers: They may be plan members! What does caring for a loved one mean for those supporting cancer patients?
- The role of the insurer: How is the public payer system influencing private group insurance? What will insurers cover? IV? Orals?
Who Should Attend?
Plan sponsors (employers), plan advisors, group insurers, TPA’s, PBM’s, industry experts and patient associations.
We will be applying to the Institute for CE credits.
Free for Plan Sponsors/Employers
$99+TAX for Industry Providers
For information on the conference, please contact Lauren Harris, Conference Editor, Benefits Canada
Employers Cancer Care Summit
February 21, 2017
Fairmont Royal York Hotel, Toronto
This agenda is a draft and subject to change
8:00 - 8:55 a.m.
Breakfast and Registration
8:55 - 9:00 a.m.
9:00 - 9:30 a.m.
Session on drug trends and treatments made possible by Amgen to be announced shortly
9:30 - 10:00 a.m.
The Workplace ROI of Take Home Cancer Medications
People are living longer with chronic health issues like cancer. Consequently, there is an increasing need for resources to manage cancer care, 70-80% of which is estimated to be provided by family members and friends at home or in the community. Cancer affects family caregivers profoundly, including negative impacts on their health, quality of life, and workplace productivity. This presentation will share outcomes from a recent study examining the economic impact of take-home cancer medications on Canadian employers.
Janet Fast, professor, department of human ecology, University of Alberta (representing The Caregiver Network)
Jean-Eric Tarride, associate professor, department of health research Methods, evidence, and impact, McMaster University
10:00 - 10:30 a.m.
10:30 - 11:00 a.m.
Take Home and Take Care: Optimizing the Patient Journey outside the Cancer Centre
How will new take home therapy treatments, now out of cancer centres, integrate certain levels of care within the healthcare system and with health care providers to ensure better outcomes? This session will look at the changing environment of the patient and treatment journey, health optimization considerations and case studies showcasing the impact of take home support on outcomes for the patient.
Sandra Salama Anderson, vice-president, consulting and business development, Innomar Strategies
11:00 - 11:30 a.m.
More information on this session to be announced shortly
Employers Cancer Care Summit
February 21, 2017
Sandra Salama Anderson
Sandra Salama Anderson began her career in pharmaceuticals as a clinical research assistant more than 18 years ago. With a strong background in sales and marketing she returned to school and completed her master of business administration, which included a semester in France, focusing on European marketing strategy. After graduating, she joined Merck Frosst Canada in their specialty division focusing on the ophthalmology, urology and neurology portfolios. Anderson joined Innomar in 2005 participating in various roles including sales, marketing, market access and clinical research. During her tenure with Innomar she has worked with various pharmaceutical manufacturers and business units within the organization to implement primary and secondary market research initiatives, to build and design strategic plans, and to expand and bring innovation to marketing and market access plans. Anderson has had the opportunity to collaborate on numerous projects and strategies within a wide range of therapeutic areas encompassing biologics, orphan drugs, and most major specialty therapeutic classes with a focus on the public and private payer landscape. In addition, she has collaborated across the specialty divisions to design and build unique patient support programs for a number of specialty molecules contributing to the continued growth at Innomar Strategies. Anderson’s reimbursement and specialty pharmaceutical patient support experience has provided her with a solid foundation in market access and in the delivery of specialty molecules in the Canadian marketplace through the entire commercialization process to the patient. Anderson has presented across the industry and has developed essential market access training modules that provide a detailed real time understanding of the Canadian marketplace. Today, Anderson is responsible for the new business development and strategic consulting divisions for Innomar Strategies in Canada.
Janet Fast is a professor in the department of human ecology at the University of Alberta. She holds a doctorate in family and consumer economics from Cornell University. Throughout her career, Fast has engaged in research, policy and practice with a focus on the economics of aging and the paid work and unpaid care work of family members. Her research addresses family, labour, health and continuing care policy issues, and she is often called on to consult with or advise government policy-makers and non-government organizations on policy related to caregiving and workplace supports. She currently co-leads an international and multidisciplinary research team investigating the intersection of work and care across the life course. More recently she has become a member of the leadership team for the AGE-WELL National Centres of Excellence program focused on assistive technologies that support the health and well-being of older adults and their caregivers.
Jean-Eric Tarride is an associate professor in McMaster's department of clinical epidemiology and biostatistics and an investigator in the Programs for Assessment of Technology in Health (PATH) Research Institute, which consists of multiple research programs in economic evaluation and health technology assessment (HTA). He is the faculty director of the Trial & Economic Modeling Methodology Program (TEMMP) at PATH. Tarride is also an associate member of the department of economics at McMaster, a faculty member of the Centre for Evaluation of Medicines (CEM), St. Josephs Healthcare, Hamilton and a member of Centre for Health Economics and Policy Analysis. He has a doctorate in economics from Concordia University (2004), a master of arts in labour economics (Toulouse, 1991) and an honours bachelor of arts in econometrics (Toulouse, 1989). Tarride received a 2007 Career Scientist Award from the Ontario Ministry of Health and Long-Term Care (MOHLTC). His primary research interests are in methods for the economic evaluation of health technologies and treatment of uncertainty in health technology assessments. He has authored more than 100 peer-reviewed journal articles related to economic evaluations of healthcare technologies. Tarride has also worked for more than 10 years in the pharmaceutical industry including as director of health economics and reimbursement at AstraZeneca Canada.
For more information on the speakers, please contact Lauren Harris, Conference Editor, Benefits Canada
The Fairmont Royal York Hotel
Just steps away from our famous doors in the heart of Canada's largest metropolis is an exciting mix of activities and attractions that will leave you exhilarated. From the theater, entertainment and financial districts, to shopping, sightseeing, and world-class sports facilities, The Fairmont Royal York hotel truly is ''at the center of it all'' in Toronto.
100 Front Street West, Toronto, ON M5J 1E3
Telephone: 416 368 2511
Fax: 416 368 9040
From Lester B. Pearson International Airport
Follow signs to 427 South
From 427 South, take the Gardiner Expressway Eastbound
Follow along the Gardiner Expressway Eastbound
Take the Yonge/York/Bay Street exit
Follow along Bay Street going Northbound
Turn left onto Front Street for valet parking; entrance is on right
From Highway 401 (Eastbound or Westbound)
Exit on the Don Valley Parkway (DVP) Southbound
Exit on the Gardiner Expressway Westbound
Exit on Yonge Street North
Left on Front Street (Westbound)
Pass one set of lights (Bay Street)
Hotel is on right-hand side, across from Union Station
Valet Parking is available at the east doors of the hotel, off Front Street. In-and-out privileges are included.
Overnight rate for Registered Guests: $42.00
30 minutes or less: $11.00
One hour or less: $16.00
One hour, 30 minutes or less: $21.00
Two hours or less: $26.00
Daytime maximum (7:00 a.m. to 5:00 p.m.) or over two hours: $34.00
Evening function rate (5:00 p.m. to 1:00 a.m.): $31.00
For more information, please contact Joanne Boccia, Event Manager
For sponsorship information contact Francesca Allman at 416-764-3883 or Francesca.Allman@tc.tc
For information on the agenda, please contact Lauren Harris, Conference Editor, Benefits Canada
Interested in becoming a sponsor?
Please email Francesca Allman
or call (416) 764-3883.